Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia: Retrospective, A 4-Year Mirror-Image Study : Journal of Clinical Psychopharmacology

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Original Contributions

Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia

Retrospective, A 4-Year Mirror-Image Study

Horikoshi, Sho MD, PhD1,2; Miura, Itaru MD, PhD1; Mui, Akihiro MD3; Hikichi, Takeshi PhD4; Aono, Tetsuro MD, PhD4; Hoshino, Ken-yo MD, PhD4; Terayama, Kenji MD, PhD4; Yabe, Hirooki MD, PhD1

Author Information
Journal of Clinical Psychopharmacology: 11/12 2022 - Volume 42 - Issue 6 - p 526-529
doi: 10.1097/JCP.0000000000001599
  • Buy

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.